Neulasta and Shortness of breath - from FDA reports


Summary

Shortness of breath is found among people who take Neulasta, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Taxotere, and have Breast cancer metastatic. This review analyzes which people have Shortness of breath with Neulasta. It is created by eHealthMe based on reports of 26,288 people who have side effects when taking Neulasta from FDA , and is updated regularly.

What to expect?

If you take Neulasta and have Shortness of breath, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Neulasta and have Shortness of breath

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Sep, 20, 2017

26,288 people reported to have side effects when taking Neulasta.
Among them, 1,177 people (4.48%) have Shortness of breath


Number of reports submitted per year:

Could Neulasta cause Shortness of breath?

Time on Neulasta when people have Shortness of breath *:

  • < 1 month: 71.43 %
  • 1 - 6 months: 26.53 %
  • 6 - 12 months: 1.22 %
  • 1 - 2 years: 0.82 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Shortness of breath when taking Neulasta *:

  • female: 70.15 %
  • male: 29.85 %

Age of people who have Shortness of breath when taking Neulasta *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.12 %
  • 20-29: 4.23 %
  • 30-39: 6.23 %
  • 40-49: 19.39 %
  • 50-59: 23.03 %
  • 60+: 47.0 %

Top conditions involved for these people *:

  • Breast Cancer Metastatic (47 people, 3.99%)
  • Metastases To Bone (43 people, 3.65%)
  • Nausea (42 people, 3.57%)
  • Preventive Health Care (38 people, 3.23%)
  • Pain (38 people, 3.23%)

Top co-used drugs for these people *:

  • Taxotere (227 people, 19.29%)
  • Dexamethasone (196 people, 16.65%)
  • Cyclophosphamide (192 people, 16.31%)
  • Zometa (173 people, 14.70%)
  • Decadron (153 people, 13.00%)

Top other side effects for these people *:

  • Fatigue (320 people, 27.19%)
  • Chest Pain (258 people, 21.92%)
  • Pain (230 people, 19.54%)
  • Fever (225 people, 19.12%)
  • Back Pain (206 people, 17.50%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Shortness of breath when taking Neulasta?

Expand the study to include all drugs with the same ingredients

Shortness of breath and drugs with ingredients of pegfilgrastim.

Expand the study to include reports from both FDA and eHealthMe

Shortness of breath and Neulasta from FDA and eHealthMe reports

Neulasta

Neulasta has active ingredients of pegfilgrastim. It is often used in agranulocytosis. (latest outcomes from Neulasta 26,406 users)

Shortness of breath

Shortness of breath has been reported by people with high blood pressure, chronic obstructive pulmonary disease, asthma, primary pulmonary hypertension, rheumatoid arthritis (latest reports from 313,725 Shortness of breath patients).

Browse all side effects of Neulasta

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Shortness of breath

Shortness of breath

Could your condition cause Shortness of breath

Shortness of breath

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Neulasta and have Shortness of breath.

Questions to the study

More questions >

User reviews to the study

More reviews >